Edition:
United States

IRadimed Corp (IRMD.OQ)

IRMD.OQ on NASDAQ Stock Exchange Capital Market

13.25USD
15 Dec 2017
Change (% chg)

$0.15 (+1.15%)
Prev Close
$13.10
Open
$13.20
Day's High
$13.30
Day's Low
$13.10
Volume
4,048
Avg. Vol
4,949
52-wk High
$14.95
52-wk Low
$7.85

Chart for

About

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $139.86
Shares Outstanding(Mil.): 10.56
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-Iradimed Corporation says Q3 GAAP earnings per share $0.02

* Iradimed corporation announces third quarter 2017 financial results

Oct 30 2017

BRIEF-Iradimed announces FDA 510(k) nod for MRI compatible patient vital signs monitor

* Iradimed corporation announces fda 510(k) clearance of MRI compatible patient vital signs monitor Source text for Eikon: Further company coverage:

Oct 26 2017

BRIEF-Iradimed Corp reports Q2 EPS $0.03

* Iradimed Corp announces second quarter 2017 financial results

Jul 28 2017

Earnings vs. Estimates